wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q46175382-48292B79-F984-43D3-9A14-5E6972A03008
Q46175382-48292B79-F984-43D3-9A14-5E6972A03008
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46175382-48292B79-F984-43D3-9A14-5E6972A03008
Evaluation of the safety and tolerability of rivaroxaban in dogs with presumed primary immune-mediated hemolytic anemia.
P2860
Q46175382-48292B79-F984-43D3-9A14-5E6972A03008
BestRank
Statement
http://www.wikidata.org/entity/statement/Q46175382-48292B79-F984-43D3-9A14-5E6972A03008
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a4f5b13a016b3e329e2616236b4af491d6c2bf11
P2860
The direct factor Xa inhibitor Rivaroxaban reduces platelet activation in congestive heart failure.